Position
Squarepoint Ops LLC in C4 Therapeutics, Inc.
Back to the book · All holders of CCCC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $29.3K$1.91 → $2.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 136.1K | $259.9K | — | — | — | 0.0% |
| Q1 2026 | 40.7K | $106.9K | $2.63 | $29.3K | −$182.2K | 0.0% |